FDA APPROVES REDUCED MONITORING TIME FOR FIRST TWO DOSES OF IMDELLTRA®
Go back to FDA APPROVES REDUCED MONITORING TIME FOR FIRST TWO DOSES OF IMDELLTRA®| Amgen Inc (NASDAQ: AMGN) | Delayed: 461.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $461.26 | 52 Week High | $176.85 | |||
| Open | $461.26 | 52 Week Low | $133.64 | |||
| Day High | $461.26 | P/E | 69.47 | |||
| Day Low | $461.26 | EPS | $6.64 | |||
| Volume | 74,123 | |||||



